期刊文献+
共找到7篇文章
< 1 >
每页显示 20 50 100
Predicting Delivery Error Using a DICOM-RT Plan for Volumetric Modulated Arc Therapy
1
作者 Hideharu Miura Masao Tanooka +6 位作者 Masayuki Fujiwara Yasuhiro Takada Hiroshi Doi Soichi Odawara Kengo Kosaka Norihiko Kamikonya Shozo Hirota 《International Journal of Medical Physics, Clinical Engineering and Radiation Oncology》 2014年第2期82-87,共6页
The purpose of this study was to investigate the prediction of mechanical error using DICOM-RT plan parameters for volumetric modulated arc therapy (VMAT). We created plans for gantry rotation arcs of 360° and 18... The purpose of this study was to investigate the prediction of mechanical error using DICOM-RT plan parameters for volumetric modulated arc therapy (VMAT). We created plans for gantry rotation arcs of 360° and 180° (full-arc and half-arc VMAT) for six maxillary sinus cancer cases using a Monaco treatment planning system, and delivered the doses with a linear accelerator. We calculated DICOM-RT plan parameters, including gantry, multileaf collimator (MLC) positions and Monitor Units (MU). We compared plans with regard to gantry angle per MU (degrees/MU) and MLC travel per MU (mm/MU) for each segment. Calculated gantry angle/MLC position speeds and errors were evaluated by comparison with the log file. On average, the half-arc VMAT plan resulted in 47% and 35% fewer degrees/MU and mm/MU than the full-arc VMAT plan, respectively. The root mean square (r.m.s.) gantry and MLC speeds showed a linear relationship with calculated degrees/MU and mm/MU, with coefficients of determination (R2) of 0.86 and 0.72, respectively. The r.m.s. gantry angle and MLC position errors showed a linear relationship with calculated degrees/MU and mm/MU with R2 of 0.63 and 0.76, respectively. Deviations from plan parameters were related to mechanical error for VMAT, and provided quantitative information without the need for VMAT delivery. These parameters can be used in the selection of treatment planning. 展开更多
关键词 volumetric-modulated arc therapy DICOM-RT PLAN PATIENT-SPECIFIC QA RADIOtherapy Planning COMPUTER-ASSISTED
下载PDF
Evaluation of 3D-CRT and VMAT Radiotherapy Plans for Left Breast Cancer with Regional Lymph Nodes Irradiation
2
作者 Houda Benmessaoud Hasnae Bouhia +4 位作者 Halima Ahmut Sanaa El Majjaoui Hanane El Kacemi Khalid Hassouni Tayeb Kebdani 《Journal of Cancer Therapy》 2023年第8期345-352,共15页
Introduction: Radiation therapy after breast surgery is an integral part of the treatment of early breast cancer. The goal of radiation therapy is to achieve the best possible coverage of the planning target volume (P... Introduction: Radiation therapy after breast surgery is an integral part of the treatment of early breast cancer. The goal of radiation therapy is to achieve the best possible coverage of the planning target volume (PTV), while reducing the dose to organs at risk (OARs) which are normal tissues whose sensitivity to irradiation could cause damage that can lead to modification of the treatment plan. In the last decade, radiation oncologist started to use the Intensity Modulated Radiotherapy (IMRT) and Volumetric Modulated Arc Therapy (VMAT) for irradiating the breast, in order to achieve better dose distribution and target dose to the PTV and OAR. The aim of this study is to compare 2 external radiotherapy techniques (VMAT vs 3D) for patients with node-positive left breast cancer. Patients and Methods: We randomly selected 10 cases of postoperative radiotherapy for breast cancer in our hospital. The patients are all female, the average age was 45.4 years old, and the primary lesions are left breast. The ANOVA test was used to compare the mean difference between subgroups, and the p value Results: Dose volume histogram (DVH) was used to analyze each evaluation dose of clinical target volume (CTV) and organs at risk (OARs). Compared to 3DCRT plans, VMAT provided more uniform coverage to the breast and regional lymph nodes. The max point dose for tVMAT was lower on average (106.4% for VMAT versus 109% for 3DCRT). OAR sparing was improved with tVMAT, with a lower average V17Gy for the left lung (27.91% for VMAT versus 30.04% for 3DCRT, p and lower for V28Gy (13.75% for VMAT versus 22.34% for 3DCRT, p = 0.01). We also found a lower V35Gy for the heart on VMAT plan (p = 0.02). On the contrary, dose of contralateral breast was lower in 3DCRT than VMAT (0.59 Gy vs 3.65 Gy, p = 0.00). Conclusion: The both types of plans can meet the clinical dosimetry demands of postoperative radiotherapy for left breast cancer. The VMAT plan has a better conformity, but 3CDRT can provide a lower dose to the contralateral organs (breast and lung) to avoid the risk of secondary cancers. 展开更多
关键词 volumetric-modulated arc therapy 3D-Conformal Radiation therapy Left Breast Cancer Target Volumes Treatment Plan
下载PDF
Oral contrast agents lead to underestimation of dose calculation in volumetric-modulated arc therapy planning for pelvic irradiation
3
作者 Hao Jing Yuan Tian +12 位作者 Yu Tang Shu-Lian Wang Jing Jin Yong-Wen Song Yue-Ping Liu Hui Fang Bo Chen Shu-Nan Qi Yuan Tang Ning-Ning Lu Yong Yang Ning Li Ye-Xiong Li 《Chinese Medical Journal》 SCIE CAS CSCD 2020年第17期2061-2070,共10页
Background:The effects of oral contrast agents(OCAs)on dosimetry have not been studied in detail.Therefore,this study aimed to examine the influence of OCAs on dose calculation in volumetric-modulated arc therapy plan... Background:The effects of oral contrast agents(OCAs)on dosimetry have not been studied in detail.Therefore,this study aimed to examine the influence of OCAs on dose calculation in volumetric-modulated arc therapy plans for rectal cancer.Methods:From 2008 to 2016,computed tomography(CT)images were obtained from 33 rectal cancer patients administered OCA with or without intravenous contrast agent(ICA)and 14 patients who received no contrast agent.CT numbers of organs at risk were recorded and converted to electronic densities.Volumetric-modulated arc therapy plans were designed before and after the original densities were replaced with non-enhanced densities.Doses to the planned target volume(PTV)and organs at risk were compared between the plans.Results:OCA significantly increased the mean and maximum densities of the bowels,while the effects of ICA on these parameters depended on the blood supply of the organs.With OCA,the actual doses for PTV were significantly higher than planned and doses to the bowel increased significantly although moderately.However,the increase in the volume receiving a high-range doses was substantial the absolute change of intestine volume receiving≥52 Gy:1.46[0.05-3.99,cubic centimeter range:-6.74 to 128.12],the absolute change of colon volume receiving≥50 Gy:0.34[0.01-1.53 cc,range:-0.08 to 3.80 cc].Dose changes due to ICA were insignificant.Pearson correlation showed that dose changes were significantly correlated with a high intestinal volume within or near the PTV(ρ>0.5,P<0.05)and with the density of enhanced intestine(ρ>0.3,P<0.05).Conclusions:Contrast agents applied in simulation cause underestimation of doses in actual treatment.The overdose due to ICA was slight,while that due to OCA was moderate.The bowel volume receiving≥50Gy was dramatically increased when OCA within the bowel was absent.Physicians should be aware of these issues if the original plan is barely within clinical tolerance or if a considerable volume of enhanced intestine is within or near the PTV. 展开更多
关键词 Oral contrast agents Simulation DOSIMETRY Organ at risk volumetric-modulated arc therapy
原文传递
Dosimetric comparison of tomotherapy and volumetric-modulated arc therapy for children with neuroblastoma
4
作者 Xia Liu Zhikai Liu +2 位作者 Tingtian Pang Tingting Dong Jie Qiu 《Pediatric Investigation》 CSCD 2020年第3期186-191,共6页
Importance:Irradiation treatment for pediatric patients with neuroblastoma represents a major challenge due to the pediatric dose limits for critical structures and the necessity of sufficient dose coverage of the cli... Importance:Irradiation treatment for pediatric patients with neuroblastoma represents a major challenge due to the pediatric dose limits for critical structures and the necessity of sufficient dose coverage of the clinical target volume for local control.Objective:To investigate dosimetric differences between tomotherapy(TOMO)and volumetric-modulated arc therapy(VMAT)as retroperitoneal radiotherapy for children with neuroblastoma.Methods:Eight patients who received retroperitoneal radiotherapy for neuroblastoma were selected for comparison of TOMO and VMAT treatment plans.The D min,D max,D mean,D 95,D 2,and D 98 of planning target volume(PTV),conformity index(CI),heterogeneity index(HI),and organs at risk(OARs)parameters were compared.Delivery machine unit(MU)and image-guide radiotherapy solution results were also compared.Results:All patients received a cumulative dose of 19.5 Gy to the PTV.VMAT showed higher CI(0.93±0.02),compared with TOMO(0.87±0.03,P<0.001).Notably,the average PTV HI was significantly better using TOMO(1.05±0.01)than VMAT(1.08±0.02,P=0.003).Compared with VMAT,the D min,D 95,and D 98 all exhibited increases in TOMO;D max variation was less than 1%in TOMO.The D 0.1cc for the spinal cord and D 2cc for the small intestine were better in TOMO in terms of OARs.However,TOMO had more MUs and required a longer delivery time.Interpretation:Both planning techniques are capable of producing high-quality treatment plans.TOMO is superior for PTV coverage,but inferior for CI.TOMO requires extra treatment time;its cost is greater than the cost of VMAT. 展开更多
关键词 TOMOtherapy volumetric-modulated arc therapy NEUROBLASTOMA Dosimetric comparison PEDIATRIC
原文传递
大分割容积旋转调强放疗与常规分割动态调强放疗治疗老年NSCLC的近期疗效观察 被引量:1
5
作者 包德强 吴畅 +1 位作者 杨东晓 李泳慧 《海南医学》 CAS 2023年第5期637-641,共5页
目的比较大分割容积旋转调强放疗与常规分割动态调强放疗治疗老年非小细胞肺癌(NSCLC)的近期疗效和不良反应。方法选择2020年1月至2021年9月南部战区海军第一医院肿瘤放疗科收治的66例老年NSCLC患者为研究对象,按随机数表法分为研究组... 目的比较大分割容积旋转调强放疗与常规分割动态调强放疗治疗老年非小细胞肺癌(NSCLC)的近期疗效和不良反应。方法选择2020年1月至2021年9月南部战区海军第一医院肿瘤放疗科收治的66例老年NSCLC患者为研究对象,按随机数表法分为研究组和对照组各33例,研究组患者开展大分割容积旋转调强放射治疗,对照组患者实施常规分割动态调强放射治疗,两组共治疗4周。比较两组患者治疗4周后的疗效、不良反应和危及器官的受量;比较两组患者治疗前及治疗4周后的肿瘤标志物[癌胚抗原(CEA)、糖抗原125(CA125)]、T淋巴细胞亚群[T淋巴细胞(CD3^(+))、辅助性T细胞(CD4^(+))、细胞毒性T细胞(CD8^(+))、CD4^(+)/CD8^(+)]、血小板-淋巴细胞比值(PLR)和中性粒细胞-淋巴细胞比值(NLR)。结果研究组患者的治疗总有效率为84.85%,明显高于对照组的60.61%,差异有统计学意义(P<0.05);研究组患者的总不良反应发生率为12.12%,明显低于对照组的36.36%,危及心脏、肺部、脊髓的受量明显低于对照组,差异均有统计学意义(P<0.05);治疗前,两组患者的肿瘤标志物、T淋巴细胞亚群、PLR、NLR比较差异均无统计学意义(P>0.05);治疗后,研究组患者的CEA、CA125、PLR、NLR、CD3^(+)、CD4^(+)、CD4^(+)/CD8^(+)明显低于对照组,但CD8^(+)明显高于对照组,差异均有统计学意义(P<0.05)。结论与常规分割动态调强放疗治疗比较,大分割容积旋转调强放射治疗老年NSCLC的效果更好,其不仅能够改善肿瘤标志物,减少不良反应,减轻炎性反应及免疫抑制,同时还能降低危及器官的受量,值得临床推广应用。 展开更多
关键词 NSCLC 大分割容积旋转调强放射 肿瘤标志物 常规分割动态调强放射 疗效 不良反应
下载PDF
大分割容积旋转调强放射治疗老年肺癌近期疗效观察 被引量:4
6
作者 殷海涛 任洪荣 +3 位作者 周冲 周云 温翠侠 胡翔 《实用老年医学》 CAS 2018年第8期726-729,共4页
目的比较大分割容积旋转调强放射治疗(HF-VMAT)与常规分割动态调强放射治疗(IMRT)对老年非小细胞肺癌的近期疗效与不良反应。方法 41例老年非小细胞肺癌病人随机分组,20例行HF-VMAT,DT60 Gy/10-12f,21例行IMRT,DT 60 Gy/30f,放疗后1个... 目的比较大分割容积旋转调强放射治疗(HF-VMAT)与常规分割动态调强放射治疗(IMRT)对老年非小细胞肺癌的近期疗效与不良反应。方法 41例老年非小细胞肺癌病人随机分组,20例行HF-VMAT,DT60 Gy/10-12f,21例行IMRT,DT 60 Gy/30f,放疗后1个月观察近期疗效及不良反应。结果 41例病人均顺利完成治疗,HF-VMAT组脊髓、食管、大血管的受量较IMRT组低(P<0.05)。HF-VMAT组部分缓解(PR)16例(80.00%),IMRT组PR 12例(57.14%),差异无统计学意义(χ2=1.53,P=0.22)。近期不良反应均为可控的1~2级肺、食管放射损伤,HF-VMAT组放射性肺损伤4例、IMRT组7例(χ2=0.37,P=0.54),HF-VMAT组放射性食管损伤6例、IMRT组14例(χ2=4.14,P=0.04)。结论 HF-VMAT对老年肺癌近期疗效较好,危及器官受量较少,不良反应较低。 展开更多
关键词 老年人 肺癌 大分割 容积旋转调强放射治疗 近期疗效
下载PDF
瘤床同步推量在早期乳腺癌保乳术后大分割容积调强放疗中的可行性及安全性 被引量:4
7
作者 郑斯明 胡冰霜 +4 位作者 周嘉雄 李民英 古定标 李珍 余建荣 《肿瘤研究与临床》 CAS 2022年第10期750-754,共5页
目的探讨瘤床同步推量(SIB)技术应用于早期乳腺癌保乳术后大分割容积调强放疗(VMAT)的可行性及患者不良反应。方法选取中山市人民医院2019年9月至2021年5月收治的67例早期乳腺癌保乳术后患者,均采用VMAT-SIB技术照射整个乳房和瘤床,全... 目的探讨瘤床同步推量(SIB)技术应用于早期乳腺癌保乳术后大分割容积调强放疗(VMAT)的可行性及患者不良反应。方法选取中山市人民医院2019年9月至2021年5月收治的67例早期乳腺癌保乳术后患者,均采用VMAT-SIB技术照射整个乳房和瘤床,全乳剂量和瘤床剂量分别为每3周40.5 Gy/15次和48 Gy/15次,评估危及器官的受照剂量,评价放疗急性不良反应。结果全乳计划靶区(PTV_(WB))和瘤床计划靶区(PTV_(BOOST))剂量分别为(42.0±2.1)Gy和(49.9±0.8)Gy,PTV_(WB)的V_(95%)和V_(105%)分别为(98.8±1.2)%和(31.4±11.3)%;PTV_(BOOST)的V_(95%)和V_(105%)分别为(99.8±0.6)%和(22.9±10.2)%,V_(5Gy)、V_(20Gy)、V_(30Gy)及平均剂量(D_(mean))分别为(52.4±12.0)%、(15.3±4.5)%、(6.7±2.2)%及(11.0±2.4)Gy;心脏的V_(18Gy)、V_(40Gy)分别为3.80%(0.48%,9.60%)、0(0,0.16%),D_(mean)为(6.7±2.1)Gy。放疗结束时,19例(29%)患者的急性皮肤不良反应为0级,41例(61%)患者出现放射性红斑,5例(7%)患者出现放射性干性脱皮,2例(3%)患者出现湿性脱皮,主要位于乳头、乳晕区及乳房皱褶处。未出现3、4级皮肤不良反应,乳房肿胀及乳房疼痛患者分别为9例(13%)和7例(10%)。随访期间未发现患者发生局部区域复发及远处转移,2年无病生存率为100%。结论VMAT-SIB技术治疗早期乳腺癌是可行的,且早期不良反应轻,耐受性良好。 展开更多
关键词 乳腺肿瘤 保乳术 同步瘤床推量 大分割放疗 容积旋转调强
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部